Alzheimer's disease (AD), the most common form of dementia, is characterized by the progressive loss of neurons and synapses, and by extracellular deposits of amyloid-β (Aβ) as senile plaques, Aβ deposits in the cerebral blood vessels, and intracellular inclusions of hyperphosphorylated tau in the form of neurofibrillary tangles. Several mechanisms contribute to AD development and progression, and increasing epidemiological and molecular evidence suggests a key role of cholesterol in its initiation and progression. Altered cholesterol metabolism and hypercholesterolemia appear to play fundamental roles in amyloid plaque formation and tau hyperphosphorylation. Over the last decade, growing evidence supports the idea that cholesterol oxidation products, known as oxysterols, may be the missing link between altered brain cholesterol metabolism and AD pathogenesis, as their involvement in neurotoxicity, mainly by interacting with Aβ peptides, is reported.

The link between altered cholesterol metabolism and Alzheimer's disease

GAMBA, Paola Francesca;TESTA, GABRIELLA;SOTTERO, Barbara;GARGIULO, Simona;POLI, Giuseppe;LEONARDUZZI, Gabriella Marisa
2012

Abstract

Alzheimer's disease (AD), the most common form of dementia, is characterized by the progressive loss of neurons and synapses, and by extracellular deposits of amyloid-β (Aβ) as senile plaques, Aβ deposits in the cerebral blood vessels, and intracellular inclusions of hyperphosphorylated tau in the form of neurofibrillary tangles. Several mechanisms contribute to AD development and progression, and increasing epidemiological and molecular evidence suggests a key role of cholesterol in its initiation and progression. Altered cholesterol metabolism and hypercholesterolemia appear to play fundamental roles in amyloid plaque formation and tau hyperphosphorylation. Over the last decade, growing evidence supports the idea that cholesterol oxidation products, known as oxysterols, may be the missing link between altered brain cholesterol metabolism and AD pathogenesis, as their involvement in neurotoxicity, mainly by interacting with Aβ peptides, is reported.
1259
54
64
Alzheimer's disease; cholesterol; oxysterols; amyloid-β; oxidative stress; neurotoxicity
Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
File in questo prodotto:
File Dimensione Formato  
Gamba et al. 2012.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 611.16 kB
Formato Adobe PDF
611.16 kB Adobe PDF Visualizza/Apri
Gamba et al 2012.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 776.88 kB
Formato Adobe PDF
776.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/36291
Citazioni
  • ???jsp.display-item.citation.pmc??? 46
  • Scopus 88
  • ???jsp.display-item.citation.isi??? 86
social impact